Skip to main content
Clinical Trials/NCT05078918
NCT05078918
Recruiting
N/A

Development and Evaluation of Comprehensive Care Program for Their Return to Normal Life and Community Among Lung Cancer Survivors

Samsung Medical Center1 site in 1 country800 target enrollmentSeptember 8, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Samsung Medical Center
Enrollment
800
Locations
1
Primary Endpoint
Mental adjustment to cancer at 6 months after surgery
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to develop a comprehensive care program for their return to normal life and community among lung cancer survivors and evaluate the effectiveness of the program.

Detailed Description

Lung cancer patients scheduled for curative surgery will be enrolled in this study. The comprehensive care program will be developed, and provided to the intervention group before and after surgery. Outcomes will be assessed 6 months and 1 year after surgery. To evaluate the effectiveness of the program, a control group will be enrolled first and used as a comparator.

Registry
clinicaltrials.gov
Start Date
September 8, 2021
End Date
February 28, 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dong Wook Shin

Professor of Family Medicine

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with non-small cell lung cancer(NSCLC) and scheduled for curative resection.
  • NSCLC with clinical stage Ⅰ-Ⅲ
  • Patients who understood the study and gave written informed consent.

Exclusion Criteria

  • Recurred lung cancer
  • Patients with extra-pulmonary synchronous double primary cancer.
  • Patients with history of other cancer diagnosis or treatment in the last 3 years.
  • Drop Criteria:
  • When surgery was canceled or pathologic stage IV was confirmed after surgery.
  • When the tumor was not found to be non-small cell lung cancer, including benign tumor, after surgery
  • Withdrawal informed consent.

Outcomes

Primary Outcomes

Mental adjustment to cancer at 6 months after surgery

Time Frame: 6 months after surgery

The Mini-Mental Adjustment to Cancer (Mini-MAC) scale, a short form instrument derived from the MAC and designed to measure coping with cancer. The scale consists of 29 items and 5 sub-dimensions as follows: Fighting spirit, helplessness/hopelessness, anxious preoccupation, fatalism and cognitive avoidance. The mini-MAC is a Likert type scale with four response options: (1) definitely does not apply to me (2) does not apply to me (3) applies to me (4) definitely applies to me.

Secondary Outcomes

  • Quality of life (EORTC QLQ-C30)(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Lung cancer specific symptoms(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Dyspnea (mMRC)(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Dyspnea (CAT)(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Unmet Needs(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Anxiety and depression(Before surgery (baseline) and 6, 12 months after surgery)
  • Physical Activity(Before surgery (baseline) and 1, 6, 12 months after surgery)
  • Mental adjustment to cancer(Before surgery (baseline) and 12 months after surgery)
  • Distress(Before surgery (baseline) and 1, 6, 12 months after surgery)

Study Sites (1)

Loading locations...

Similar Trials